{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:18:26Z","timestamp":1767665906246},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/rhu.0b013e31819db6db","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T19:05:25Z","timestamp":1242932725000},"page":"127-129","source":"Crossref","is-referenced-by-count":8,"title":["Acrocyanosis From Phenazopyridine-Induced Sulfhemoglobinemia Mistaken for Raynaud Phenomenon"],"prefix":"10.1097","volume":"15","author":[{"given":"Tanaz A.","family":"Kermani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorin V.","family":"Pislaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas G.","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210207","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jama.1951.03670010028007","article-title":"Methemoglobinemia associated with pyridium administration; report of a case.","volume":"146","author":"Crawford","year":"1951","journal-title":"J Am Med Assoc"},{"key":"R2-7-20210207","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/106002808201600212","article-title":"Acquired methemoglobinemia and hemolytic anemia after usual doses of phenazopyridine.","volume":"16","author":"Jeffery","year":"1982","journal-title":"Drug Intell Clin Pharm"},{"key":"R3-7-20210207","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0002-9343(91)90135-K","article-title":"Phenazopyridine-induced sulfhemoglobinemia: inadvertent rechallenege.","volume":"91","author":"Halvorsen","year":"1991","journal-title":"Am J Med"},{"key":"R4-7-20210207","first-page":"386","article-title":"Acquired sulfhemoglobinemia-an underreported diagnosis?","volume":"169","author":"Noor","year":"1998","journal-title":"West J Med"},{"key":"R5-7-20210207","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1345\/aph.1E557","article-title":"Phenazopyridine-induced sulfhemoglobinemia.","volume":"39","author":"Gopalachar","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R6-7-20210207","first-page":"1046","article-title":"Wintrobes clinical hematology. 10th ed.","author":"Lukens","year":"1999"},{"key":"R7-7-20210207","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/clinchem\/43.6.1098","article-title":"Pitfalls in discriminating sulfhemoglobinemia from methemoglobinemia [letter].","volume":"43","author":"Demedts","year":"1997","journal-title":"Clin Chem"},{"key":"R8-7-20210207","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0009-8981(72)90380-4","article-title":"Hemoglobin pigments. Spectrophotometric determination of oxy-carboxy-met and sulfhemoglobin in capillary blood.","volume":"42","author":"Siggaard-Andersen","year":"1972","journal-title":"Clin Chim Acta"},{"key":"R9-7-20210207","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1176\/ajp.140.7.913","article-title":"Imipramine-induced vasospasm: a case report.","volume":"140","author":"Appelbaum","year":"1983","journal-title":"Am J Psychiatry"},{"key":"R10-7-20210207","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/adc.63.2.204","article-title":"Acrocyanosis due to imipramine.","volume":"63","author":"Anderson","year":"1988","journal-title":"Arch Dis Child"},{"key":"R11-7-20210207","first-page":"420","article-title":"Visage mauve (? from imipramine).","volume":"83","author":"Hare","year":"1970","journal-title":"Br J Dermatol"},{"key":"R12-7-20210207","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0190-9622(91)70204-F","article-title":"Imipramine hyperpigmentation: a slate-gray discoloration caused by long-term imipramine administration.","volume":"25","author":"Hashimoto","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"R13-7-20210207","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0190-9622(99)70182-9","article-title":"Imipramine-induced hyperpigmentation: four cases and a review of the literature.","volume":"40","author":"Ming","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"R14-7-20210207","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1345\/aph.1C431","article-title":"Imipramine-induced hyperpigmentation.","volume":"37","author":"Dean","year":"2003","journal-title":"Ann Pharmacother"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00124743-200904000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:02:20Z","timestamp":1618038140000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124743-200904000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e31819db6db","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}